Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue bi...
Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
About this item
Full title
Author / Creator
Publisher
Germany: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
Germany: BioMed Central
Subjects
More information
Scope and Contents
Contents
Prostate cancer (PCa) is one of the most common cancers among men worldwide. Current screening methods for PCa display limited sensitivity and specificity, not stratifying for disease aggressiveness. Hence, development and validation of new molecular markers is needed. Aberrant gene promoter methylation is common in PCa and has shown promise as cli...
Alternative Titles
Full title
Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_aad11a380f1d41deb4ee52d897dc5a76
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_aad11a380f1d41deb4ee52d897dc5a76
Other Identifiers
ISSN
1868-7075,1868-7083
E-ISSN
1868-7083,1868-7075
DOI
10.1186/s13148-018-0564-2
